EcoDrugPlus

Ensembl ID : ENSOMYG00000030788
Gene Symbol: -
Cross references: -
155 Possible Orthologues:

Ensembl ID : ENSOMYG00000030815
Gene Symbol: -
Cross references: -
174 Possible Orthologues:

Ensembl ID : ENSOMYG00000030842
Gene Symbol: -
Cross references: -
149 Possible Orthologues:

Ensembl ID : ENSOMYG00000061357
Gene Symbol: -
Cross references: -
350 Possible Orthologues:

Ensembl ID : ENSOMYG00000053247
Gene Symbol: -
Cross references: -
179 Possible Orthologues:

Ensembl ID : ENSOMYG00000052857
Gene Symbol: -
Cross references: -
189 Possible Orthologues:

Ensembl ID : ENSOMYG00000052012
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Ensembl ID : ENSOMYG00000049257
Gene Symbol: -
Cross references: -
239 Possible Orthologues:

Ensembl ID : ENSOMYG00000046473
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Ensembl ID : ENSOMYG00000031377
Gene Symbol: -
Cross references: -
226 Possible Orthologues:

Ensembl ID : ENSOMYG00000031459
Gene Symbol: -
Cross references: -
216 Possible Orthologues:

Ensembl ID : ENSOMYG00000031739
Gene Symbol: -
Cross references: -
382 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).